From Casetext: Smarter Legal Research

Altana Pharma AG v. Teva Pharm. USA, Inc.

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY
Dec 20, 2012
Civil Action No. 04-2355 (JLL) (D.N.J. Dec. 20, 2012)

Opinion

Civil Action No. 04-2355 (JLL)

12-20-2012

ALTANA PHARMA AG and WYETH, Plaintiffs, v. TEVA PHARMACEUTICALS USA, INC., et al., Defendants.


NOT FOR PUBLICATION

ORDER

LINARES, District Judge.

This matter comes before the Court by way of Defendant Sun's motion for partial summary judgment [Docket Entry No. 1118] seeking a ruling that it is not responsible for any alleged damages to the Plaintiffs prior to the date on which it launched its generic pantoprazole product—January 30, 2008. Based on the reasons set forth in the Court's corresponding Opinion dated December 20, 2012, which has been filed under seal,

IT IS on this 20th day of December, 2012,

ORDERED that Defendant Sun's motion for partial summary judgment [Docket Entry No. 1118] is DENIED.

IT IS SO ORDERED.

______________

Jose L. Linares

United States District Judge


Summaries of

Altana Pharma AG v. Teva Pharm. USA, Inc.

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY
Dec 20, 2012
Civil Action No. 04-2355 (JLL) (D.N.J. Dec. 20, 2012)
Case details for

Altana Pharma AG v. Teva Pharm. USA, Inc.

Case Details

Full title:ALTANA PHARMA AG and WYETH, Plaintiffs, v. TEVA PHARMACEUTICALS USA, INC.…

Court:UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

Date published: Dec 20, 2012

Citations

Civil Action No. 04-2355 (JLL) (D.N.J. Dec. 20, 2012)